Email Updates

You are here

Home

Sisters Antiretroviral therapy Programme for Prevention of HIV –an Integrated Response (SAPPH-Ire)

Status
Ongoing
Phase
Demo Project
Principal Investigator(s)
Centre for Sexual Health and HIV/AIDS Research Zimbabwe; University College London; London School of Hygiene and Tropical Medicine ; RTI; DFID; UNFPA
Objective

Seeks to enhance HIV treatment and prevention among 28,000 highway-based sex workers by increasing uptake and frequency of testing, demonstrate acceptability and feasibility of delivering PrEP, maximize retention in care, promote timely initiation of ART for those eligible, and maximize adherence to both ART and PrEP.

 

 

Prevention Option(s)
PrEP
Arms and Assigned Interventions
Products
TDF/FTC (Truvada)
Official Code
SAPPH-IRe
Trial Sponsors
Centre for Sexual Health and HIV/AIDS Research Zimbabwe; University College London; London School of Hygiene and Tropical Medicine ; RTI; DFID; UNFPA
Product Developers
Centre for Sexual Health and HIV/AIDS Research Zimbabwe; University College London; London School of Hygiene and Tropical Medicine ; RTI; DFID; UNFPA
July 2014
October 2016
Enrollment
2 800
15
Years
24
Years
Population
Women
Sites

Site(s) - Zimbabwe

Zimbabwe